The global Biobanking market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the Biobanking market's development status and future trend in the global and Japan. It splits Biobanking market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
Thermo Fisher Scientific Inc. (U.S.)
Tecan Group Ltd. (Switzerland)
Qiagen N.V. (Germany)
Hamilton Company (U.S.)
Brooks Automation (U.S.)
TTP Labtech Ltd (U.K.)
VWR Corporation (U.S.)
Promega Corporation (U.S.)
Chart Industries (U.S.)
Becton, Dickinson and Company (U.S.)
Merck KGaA (Germany)
Micronic (Netherlands)
LVL Technologies GmbH & Co. KG (Germany)
Panasonic Healthcare Holdings Co. Ltd (Japan)
Biokryo GmbH (Germany)
Biobank AS (Norway)
Biorep Technologies Inc. (U.S.)
Cell & Co Bioservices (France)
RUCDR infinite biologics (U.S.)
Modul-Bio (France)
CSols Ltd (U.K.)
Ziath (U.K.)
LabVantage Solutions Inc. (U.S.)

Geographically, this report splits the Global market into the following regions:
Asia Pacific
Japan
Tokyo
Yokohama
Osaka
Nagoya
Others
China
Korea
India
Others
Europe
France
Germany
United Kingdom
Italy
Russia
Others
North America
United States
Canada
Latin America
Brazil
Mexico
Others
Southeast Asia
Singapore
Malaysia
Vietnam
Myanmar
Thailand
Indonesia
Philippines
Others
Middle East & Africa
Saudi Arabia
Iran
UAE
Turkey
Israel
Egypt
South Africa
Others

On the basis of product, the Biobanking market is primarily split into
By Product and Service
Equipment
Consumables
Services
Software
By Sample
Blood Products
Human Tissues
Nucleic Acids
Cell Lines
Biological Fluids

Key Applications
Regenerative Medicine
Life Science Research
Clinical Research